PF-Atlas › Mechanisms › Senolytics

Senolytics in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

Senolytics is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 3 drugs and 3 clinical trials acting through this mechanism.

Drugs targeting Senolytics

Dasatinib + QuercetinNavitoclaxFisetin

Clinical trials

Dasatinib + Quercetin — NCT04262635Navitoclax — NCT05166694Fisetin — NCT04537533
Medical disclaimer. This is a research summary, not medical advice.